The family of connexin genes

Connexins: A Guide

Volumn , Issue , 2009, Pages 3-26

  Beyer, Eric C ^a   Berthoud, Viviana M ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Disease mutations; Gene structure; Nomenclature

Indexed keywords

EID: 67749120345     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-59745-489-6_1     Document Type: Chapter

References (117)

1. Paul DL. Molecular cloning of cDNA for rat liver gap junction protein. J Cell Biol. 1986;103:123-34.
2. Kumar NM, Gilula NB. Cloning and characterization of human and rat liver cDNAs coding for a gap junction protein. J Cell Biol. 1986;103:767-76.
3. Zhang JT, Nicholson BJ. Sequence and tissue distribution of a second protein of hepatic gap junctions, Cx26, as deduced from its cDNA. J Cell Biol. 1989;109:3391-401.
4. Beyer EC, Paul DL, Goodenough DA. Connexin43: a protein from rat heart homologous to a gap junction protein from liver. J Cell Biol. 1987;105:2621-9.
5. Ebihara L, Beyer EC, Swenson KI, Paul DL, Goodenough DA. Cloning and expression of a Xenopus embryonic gap junction protein. Science. 1989;243:1194-5.
6. Willecke K, Jungbluth S, Dahl E, Hennemann H, Heynkes R, Grzeschik KH. Mouse connexin37: cloning and functional expression of a gap junction gene highly expressed in lung. J Cell Biol. 1991;114:1049-57.
7. Starich TA, Lee RY, Panzarella C, Avery L, Shaw JE. eat-5 and unc-7 represent a multigene family in Caenorhabditis elegans involved in cell-cell coupling. J Cell Biol. 1996;134:537-48.
8. Ganfornina MD, Sánchez D, Herrera M, Bastiani MJ. Developmental expression and molecular characterization of two gap junction channel proteins expressed during embryogenesis in the grasshopper Schistocerca americana. Dev Genet. 1999;24:137-50.
9. Bauer R, Löer B, Ostrowski K, Martini J, Weimbs A, Lechner H, Hoch M. Intercellular communication: the Drosophila innexin multiprotein family of gap junction proteins. Chem Biol. 2005;12:515-26.
10. Panchin Y, Kelmanson I, Matz M, Lukyanov K, Usman N, Lukyanov S. A ubiquitous family of putative gap junction molecules. Curr Biol. 2000;10:R473-4.
11. Huang Y, Grinspan JB, Abrams CK, Scherer SS. Pannexin1 is expressed by neurons and glia but does not form functional gap junctions. Glia. 2007;55:46-56.
12. Locovei S, Bao L, Dahl G. Pannexin in 1 erythrocytes: function without a gap. Proc Natl Acad Sci USA. 2006;103:7655-9.
13. Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor. EMBO J. 2006;25:5071-82.
14. Bruzzone R, Hormuzdi SG, Barbe MT, Herb A, Monyer H. Pannexins, a family of gap junction proteins expressed in brain. Proc Natl Acad Sci USA. 2003;100:13644-9.
15. Vanden Abeele F, Bidaux G, Gordienko D, Beck B, Panchin YV, Baranova AV, Ivanov DV, Skryma R, Prevarskaya N. Functional implications of calcium permeability of the channel formed by pannexin 1. J Cell Biol. 2006;174:535-46.
16. Fishman GI, Spray DC, Leinwand LA. Molecular characterization and functional expression of the human cardiac gap junction channel. J Cell Biol. 1990;111:589-98.
17. Söhl G, Willecke K. Gap junctions and the connexin protein family. Cardiovasc Res. 2004;62:228-32.
18. Söhl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes. 2003;10:173-80.
19. Gimlich RL, Kumar NM, Gilula NB. Differential regulation of the levels of three gap junction mRNAs in Xenopus embryos. J Cell Biol. 1990;110:597-605.
20. Kumar NM, Gilula NB. Molecular biology and genetics of gap junction channels. Semin Cell Biol. 1992;3:3-16.
21. Eastman SD, Chen TH, Falk MM, Mendelson TC, Iovine MK. Phylogenetic analysis of three complete gap junction gene families reveals lineage-specific duplications and highly supported gene classes. Genomics. 2006;87:265-74.
22. Milks LC, Kumar NM, Houghten R, Unwin N, Gilula NB. Topology of the 32-kd liver gap junction protein determined by site-directed antibody localizations. EMBO J. 1988;7:2967-75.
23. Goodenough DA, Paul DL, Jesaitis L. Topological distribution of two connexin32 antigenic sites in intact and split rodent hepatocyte gap junctions. J Cell Biol. 1988;107:1817-24.
24. Beyer EC, Kistler J, Paul DL, Goodenough DA. Antisera directed against connexin43 peptides react with a 43-kD protein localized to gap junctions in myocardium and other tissues. J Cell Biol. 1989;108:595-605.
25. Yancey SB, John SA, Lal R, Austin BJ, Revel JP. The 43-kD polypeptide of heart gap junctions: immunolocalization, topology, and functional domains. J Cell Biol. 1989;108:2241-54.
26. Yeager M, Gilula NB. Membrane topology and quaternary structure of cardiac gap junction ion channels. J Mol Biol. 1992;223:929-48.
27. Zhang JT, Nicholson BJ. The topological structure of connexin 26 and its distribution compared to connexin 32 in hepatic gap junctions. J Membr Biol. 1994;139:15-29.
28. Hennemann H, Schwarz HJ, Willecke K. Characterization of gap junction genes expressed in F9 embryonic carcinoma cells: molecular cloning of mouse connexin31 and -45 cDNAs. Eur J Cell Biol. 1992;57:51-8.
29. Bennett MVL, Barrio LC, Bargiello TA, Spray DC, Hertzberg E, Sáez JC. Gap junctions: new tools, new answers, new questions. Neuron. 1991;6:305-20.
30. Cruciani V, Mikalsen SO. The vertebrate connexin family. Cell Mol Life Sci. 2006;63:1125-40.
31. Haefliger JA, Bruzzone R, Jenkins NA, Gilbert DJ, Copeland NG, Paul DL. Four novel members of the connexin family of gap junction proteins. Molecular cloning, expression, and chromosome mapping. J Biol Chem. 1992;267:2057-64.
32. Schwarz HJ, Chang YS, Hennemann H, Dahl E, Lalley PA, Willecke K. Chromosomal assignments of mouse connexin genes, coding for gap junctional proteins, by somatic cell hybridization. Somat Cell Mol Genet. 1992;18:351-9.
33. Krüger O, Plum A, Kim JS, Winterhager E, Maxeiner S, Hallas G, Kirchhoff S, Traub O, Lamers WH, Willecke K. Defective vascular development in connexin 45-deficient mice. Development. 2000;127:4179-93.
34. Jacob A, Beyer EC. Mouse connexin 45: genomic cloning and exon usage. DNACell Biol. 2001;20:11-19.
35. Baldridge D, Lecanda F, Shin CS, Stains J, Civitelli R. Sequence and structure of the mouse connexin45 gene. Biosci Rep. 2001;21:683-9.
36. Condorelli DF, Parenti R, Spinella F, Trovato Salinaro A, Belluardo N, Cardile V, Cicirata F. Cloning of a new gap junction gene (Cx36) highly expressed in mammalian brain neurons. Eur J Neurosci. 1998;10:1202-8.
37. Söhl G, Degen J, Teubner B, Willecke K. The murine gap junction gene connexin36 is highly expressed in mouse retina and regulated during brain development. FEBS Lett. 1998;428:27-31.
38. Pfeifer I, Anderson C, Werner R, Oltra E. Redefining the structure of the mouse connexin43 gene: selective promotor usage and alternative splicing mechanisms yield transcripts with different translational efficiencies. Nucleic Acids Res. 2004;32:4550-62.
39. Dupays L, Mazurais D, Rücker-Martin C, Calmels T, Bernot D, Cronier L, Malassiné A, Gros D, Théveniau-Ruissy M. Genomic organization and alternative transcripts of the human connexin40 gene. Gene. 2003;305:79-90.
40. Anderson CL, Zundel MA, Werner R. Variable promotor usage and alternative splicing in five mouse connexin genes. Genomics. 2005;85:238-44.
41. Hudder A, Werner R. Analysis of a Charcot-Marie-Tooth disease mutation reveals an essential internal ribosome entry site element in the connexin-32 gene. J Biol Chem. 2000;275:34586-91.
42. Pickering BM, Willis AE. The implications of structured 5' untranslated regions on translation and disease. Sem Cell Dev Biol. 2005;16:39-47.
43. Sá ez JC, Berthoud VM, Brañes MC, Martínez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 2003;83:1359-400.
44. Oyamada M, Oyamada Y, Takamatsu T. Regulation of connexin expression. Biochim Biophys Acta. 2005;1719:6-23.
45. Piersanti M, Lye SJ. Increase in messenger ribonucleic acid encoding the myometrial gap junction protein, connexin-43, requires protein synthesis and is associated with increased expression of the activator protein-1, c-fos. Endocrinology. 1995;136:3571-8.
46. Sullivan R, Ruangvoravat C, Joo D, Morgan J, Wang BL, Wang XK, Lo CW. Structure, sequence and expression of the mouse Cx43 gene encoding connexin 43. Gene. 1993;130:191-9.
47. Linhares VL, Almeida NA, Menezes DC, Elliott DA, Lai D, Beyer EC, Campos de Carvalho AC, Costa MW. Transcriptional regulation of the murine Connexin40 promotor by cardiac factors Nkx2-5, GATA4 and Tbx5. Cardiovasc Res. 2004;64:402-11.
48. Dupays L, Jarry-Guichard T, Mazurais D, Calmels T, Izumo S, Gros D, Théveniau-Ruissy M. Dysregulation of connexins and inactivation of NFATc1 in the cardiovascular system of Nkx2-5 null mutants. J Mol Cell Cardiol. 2005;38:787-98.
49. Bruneau BG, Nemer G, Schmitt JP, Charron F, Robitaille L, Caron S, Conner DA, Gessler M, Nemer M, Seidman CE, Seidman JG. A murine model of Holt-Oram syndrome defines roles of the T-box transcription factor Tbx5 in cardiogenesis and disease. Cell. 2001;106:709-21.
50. Moskowitz IP, Pizard A, Patel VV, Bruneau BG, Kim JB, Kupershmidt S, Roden D, Berul CI, Seidman CE, Seidman JG. The T-Box transcription factor Tbx5 is required for the patterning and maturation of the murine cardiac conduction system. Development. 2004;131:4107-16.
51. Bai S, Spray DC, Burk RD. Identification of proximal and distal regulatory elements of the rat connexin32 gene. Biochim Biophys Acta. 1993;1216:197-204.
52. Piechocki MP, Toti RM, Fernstrom MJ, Burk RD, Ruch RJ. Liver cell-specific transcriptional regulation of connexin32. Biochim Biophys Acta. 2000;1491:107-22.
53. Field JM, Tate LA, Chipman JK, Minchin SD. Identification of functional regulatory regions of the connexin32 gene promotor. Biochim Biophys Acta. 2003;1628:22-9.
54. Koffler LD, Fernstrom MJ, Akiyama TE, Gonzalez FJ, Ruch RJ. Positive regulation of connexin32 transcription by hepatocyte nuclear factor-1α. Arch Biochem Biophys. 2002;407:160-7.
55. Houlden H, Girard M, Cockerell C, Ingram D, Wood NW, Goossens M, Walker RW, Reilly MM. Connexin 32 promotor P2 mutations: a mechanism of peripheral nerve dysfunction. Ann Neurol. 2004;56:730-4.
56. Bondurand N, Girard M, Pingault V, Lemort N, Dubourg O, Goossens M. Human connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet. 2001;10:2783-95.
57. Piechocki MP, Burk RD, Ruch RJ. Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells. Carcinogenesis. 1999;20:401-6.
58. Martin D, Tawadros T, Meylan L, Abderrahmani A, Condorelli DF, Waeber G, Haefliger JA. Critical role of the transcriptional repressor neuron-restrictive silencer factor in the specific control of connexin36 in insulin-producing cell lines. J Biol Chem. 2003;278:53082-9.
59. Asklund T, Appelskog IB, Ammerpohl O, Ekström TJ, Almqvist PM. Histone deacetylase inhibitor 4-phenylbutyrate modulates glial fibrillary acidic protein and connexin 43 expression, and enhances gap-junction communication, in human glioblastoma cells. Eur J Cancer. 2004;40:1073-81.
60. Jung JW, Cho SD, Ahn NS, Yang SR, Park JS, Jo EH, Hwang JW, Aruoma OI, Lee YS, Kang KS. Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-Otetradecanoylphorbol-13-acetate in rat liver epithelial cells. Cancer Lett. 2005;241:301-8.
61. Ogawa T, Hayashi T, Tokunou M, Nakachi K, Trosko JE, Chang CC, Yorioka N. Suberoylanilide hydroxamic acid enhances gap junctional intercellular communication via acetylation of histone containing connexin 43 gene locus. Cancer Res. 2005;65:9771-8.
62. Hernandez M, Shao Q, Yang XJ, Luh SP, Kandouz M, Batist G, Laird DW, Alaoui-Jamali MA. A histone deacetylation-dependent mechanism for transcriptional repression of the gap junction gene cx43 in prostate cancer cells. Prostate. 2006;66:1151-61.
63. Vinken M, Henkens T, Vanhaecke T, Papeleu P, Geerts A, Van Rossen E, Chipman JK, Meda P, Rogiers V. Trichostatin A enhances gap junctional intercellular communication in primary cultures of adult rat hepatocytes. Toxicol Sci. 2006;91:484-92.
64. Schiavi A, Hudder A, Werner R. Connexin43 mRNA contains a functional internal ribosome entry site. FEBS Lett. 1999;464:118-22.
65. Lahlou H, Fanjul M, Pradayrol L, Susini C, Pyronnet S. Restoration of functional gap junctions through internal ribosome entry site-dependent synthesis of endogenous connexins in density-inhibited cancer cells. Mol Cell Biol. 2005;25:4034-45.
66. Bushati N, Cohen SM. microRNA functions. Ann Rev Cell Dev Biol. 2007;23:175-205.
67. Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res. 2006;34:5863-71.
68. Yang B, Lin H, Xiao J, Lu Y, Luo X, Li B, Zhang Y, Xu C, Bai Y, Wang H, Chen G, Wang Z. The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2. Nat Med. 2007;13:486-91.
69. Meyer J, Mai M, Ortega G, Mossner R, Lesch KP. Mutational analysis of the connexin 36 gene (CX36) and exclusion of the coding sequence as a candidate region for catatonic schizophrenia in a large pedigree. Schizoph Res. 2002;58:87-91.
70. Aleksic B, Ishihara R, Takahashi N, Maeno N, Ji X, Saito S, Inada T, Ozaki N. Gap junction coding genes and schizophrenia: a genetic association study. J Hum Genet. 2007;52:498-501.
71. Ni X, Valente J, Azevedo M, Pato M, Pato C, Kennedy JL. Connexin50 gene on human chromosome 1q21 is associated with schizophrenia in matched case-control and familybased studies. J Med Genet. 2007;44:532-6
72. White TW, Bruzzone R, Goodenough DA, Paul DL. Mouse Cx50, a functional member of the connexin family of gap junction proteins, is the lens fiber protein MP70. Mol Biol Cell. 1992;3:711-20.
73. Musso M, Balestra P, Bellone E, Cassandrini D, Di Maria E, Doria LL, Grandis M, Mancardi GL, Schenone A, Levi G, Ajmar F, Mandich P. The D355V mutation decreases EGR2 binding to an element within the Cx32 promotor. Neurobiol Dis. 2001;8:700-6.
74. Carrasquillo MM, Zlotogora J, Barges S, Chakravarti A. Two different connexin 26 mutations in an inbred kindred segregating non-syndromic recessive deafness: implications for genetic studies in isolated populations. Hum Mol Genet. 1997;6:2163-72.
75. Deschenes SM, Walcott JL, Wexler TL, Scherer SS, Fischbeck KH. Altered trafficking of mutant connexin32. J Neurosci. 1997;17:9077-84.
76. Fleishman SJ, Sabag AD, Ophir E, Avraham KB, Ben Tal N. The structural context of disease-causing mutations in gap junctions. J Biol Chem. 2006;281:28958-63.
77. Van Slyke JK, Deschenes SM, Musil LS. Intracellular transport, assembly, and degradation of wildtype and disease-linked mutant gap junction proteins. Mol Biol Cell. 2000;11:1933-46.
78. Berthoud VM, Minogue PJ, Guo J, Williamson EK, Xu X, Ebihara L, Beyer EC. Loss of function and impaired degradation of a cataract-associated mutant connexin50. Eur J Cell Biol. 2003;82:209-21.
79. Minogue PJ, Liu X, Ebihara L, Beyer EC, Berthoud VM. An aberrant sequence in a connexin46 mutant underlies congenital cataracts. J Biol Chem. 2005;280:40788-95.
80. Abrams CK, Bennett MVL, Verselis VK, Bargiello TA. Voltage opens unopposed gap junction hemichannels formed by a connexin 32 mutant associated with X-linked Charcot-Marie-Tooth disease. Proc Nat Acad Sci USA. 2002;99:3980-4.
81. Liang GS, deMiguel M, Gómez-Herná ndez JM, Glass JD, Scherer SS, MintzM, Barrio LC, Fischbeck KH. Severe neuropathy with leaky connexin32 hemichannels. Ann Neurol. 2005;57:749-54.
82. Beyer EC, Rodriguez J, Minogue PJ, Pal J, Berthoud VM, Ebihara L. Molecular mechanism underlying a congenital 'zonular nuclear' pulverulent cataract associated with a connexin50 mutation. ARVO Abstracts 2007;3635.
83. Gong X, Li L, Cheng C, White T, Mathias R, Chang B, Xia C-H, Gap junction mediated cataract formation and prevention. ARVO Abstracts 2007;3182.
84. Oh S, Ri Y, Bennett MVL, Trexler EB, Verselis VK, Bargiello TA. Changes in permeability caused by connexin 32 mutations underlie X-linked Charcot-Marie-Tooth disease. Neuron. 1997;19:927-38.
85. Bruzzone R, Cohen-Salmon M. Hearing the messenger: Ins (1, 4, 5) P3 and deafness. Nat Cell Biol. 2005;7:14-6.
86. Abrams CK, Freidin M, Bukauskas F, Dobrenis K, Bargiello TA, Verselis VK, Bennett MV, Chen L, Sahenk Z. Pathogenesis of X-linked Charcot-Marie-Tooth disease: differential effects of two mutations in connexin 32. J Neurosci. 2003;23:10548-58.
87. Pal JD, Berthoud VM, Beyer EC, Mackay D, Shiels A, Ebihara L. Molecular mechanism underlying a Cx50-linked congenital cataract. Am J Physiol. 1999;276:C1443-6.
88. Bruzzone R, Gomès D, Denoyelle E, Duval N, Perea J, Veronesi V, Weil D, Petit C, Gabellec MM, D'Andrea P, White TW. Functional analysis of a dominant mutation of human connexin26 associated with nonsyndromic deafness. Cell Commun Adhes. 2001;8:425-31.
89. Marziano NK, Casalotti SO, Portelli AE, Becker DL, Forge A. Mutations in the gene for connexin 26 (GJB2) that cause hearing loss have a dominant-negative effect on connexin 30. Hum Mol Genet. 2003;12:805-12.
90. Rouan F, White TW, Brown N, Taylor AM, Lucke TW, Paul DL, Munro CS, Uitto J, Hodgins MB, Richard G. Trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. J Cell Sci. 2001;114:2105-13.
91. Gollob MH, Jones DL, Krahn AD, Danis L, Gong XQ, Shao Q, Liu X, Veinot JP, Tang AS, Stewart AF, Tesson F, Klein GJ, Yee R, Skanes AC, Guiraudon GM, Ebihara L, Bai D. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med. 2006;354:2677-88.
92. Firouzi M, Ramanna H, Kok B, Jongsma HJ, Koeleman BP, Doevendans PA, Groenewegen WA, Hauer RN. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res. 2004;95:e29-33.
93. Boerma M, Forsberg L, Van Zeijl L, Morgenstern R, De Faire U, Lemne C, Erlinge D, Thulin T, Hong Y, Cotgreave IA. A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development. J Intern Med. 1999;246:211-8.
94. Yeh HI, Chou Y, Liu HF, Chang SC, Tsai CH. Connexin37 gene polymorphism and coronary artery disease in Taiwan. Int J Cardiol. 2001;81:251-5.
95. Wong CW, Christen T, Pfenniger A, James RW, Kwak BR. Do allelic variants of the connexin37 1019 gene polymorphism differentially predict for coronary artery disease and myocardial infarction? Atherosclerosis. 2007;191:355-61.
96. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002;347:1916-23.
97. Hirashiki A, Yamada Y, Murase Y, Suzuki Y, Kataoka H, Morimoto Y, Tajika T, Murohara T, Yokota M. Association of gene polymorphisms with coronary artery disease in low- or high-risk subjects defined by conventional risk factors. J Am Coll Cardiol. 2003;42:1429-37.
98. Listì F, Candore G, Lio D, Russo M, Colonna-Romano G, Caruso M, Hoffmann E, Caruso C. Association between C1019T polymorphism of connexin37 and acute myocardial infarction: a study in patients from Sicily. Int J Cardiol. 2005;102(2):269-71.
99. Collings A, Islam MS, Juonala M, Rontu R, Kähönen M, Hutri-Kähönen N, Laitinen T, Marniemi J, Viikari JS, Raitakari OT, Lehtimäki TJ. Associations between connexin37 gene polymorphism and markers of subclinical atherosclerosis: the Cardiovascular Risk in Young Finns study. Atherosclerosis 2007;195:379-84.
100. Kumari SS, Varadaraj K, Valiunas V, Ramanan SV, Christensen EA, Beyer EC, Brink PR. Functional expression and biophysical properties of polymorphic variants of the human gap junction protein connexin37. Biochem Biophys Res Commun. 2000;274:216-24.
101. Bergoffen J, Scherer SS, Wang S, Scott MO, Bone LJ, Paul DL, Chen K, Lensch MW, Chance PF, Fischbeck KH. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science. 1993;262:2039-42.
102. Uhlenberg B, Schuelke M, Rüschendorf F, Ruf N, Kaindl AM, Henneke M, Thiele H, Stoltenburg-Didinger G, Aksu F, Topalolu H, Nürnberg P, Hübner C, Weschke B, Grtner J. Mutations in the gene encoding gap junction protein α12 (Connexin 46.6) cause Pelizaeus-Merzbacher-like disease. Am J Hum Genet. 2004;75:251-60.
103. Liu XZ, Xia XJ, Adams J, Chen ZY, Welch KO, Tekin M, Ouyang XM, Kristiansen A, Pandya A, Balkany T, Arnos KS, Nance WE. Mutations in GJA1 (connexin 43) are associatedwithnonsyndromic autosomal recessivedeafness. Hum Mol Genet. 2001;10:2945-51.
104. Richard G, White TW, Smith LE, Bailey RA, Compton JG, Paul DL, Bale SJ. Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet. 1998;103:393-9.
105. Uyguner O, Tukel T, Baykal C, Eris H, Emiroglu M, Hafiz G, Ghanbari A, Baserer N, Yuksel-Apak M, Wollnik B. The novel R75Q mutation in the GJB2 gene causes autosomal dominant hearing loss and palmoplantar keratoderma in a Turkish family. Clin Genet. 2002;62:306-9.
106. Richard G, Rouan F, Willoughby CE, Brown N, Chung P, Ryynnen M, Jabs EW, Bale SJ, DiGiovanna JJ, Uitto J, Russell L. Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome. Am J Hum Genet. 2002;70:1341-8.
107. Heathcote K, Syrris P, Carter ND, Patton MA. A connexin 26 mutation causes a syndrome of sensorineural hearing loss and palmoplantar hyperkeratosis (MIM 148350). J Med Genet. 2000;37:50-1.
108. Maestrini E, Korge BP, Ocaña-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, Hovnanian A, Monaco AP, Munro CS. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet. 1999;8:1237-43.
109. López-Bigas N, Olivé M, Rabionet R, Ben-David O, Martínez-Matos JA, Bravo O, Banchs I, Volpini V, Gasparini P, Avraham KB, Ferrer I, Arboné s ML, Estivill X. Connexin 31 (GJB3) is expressed in the peripheral and auditory nerves and causes neuropathy and hearing impairment. Hum Mol Genet. 2001;10:947-52.
110. Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH, DiGiovanna JJ, Compton JG, Bale SJ. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet. 1998;20:366-9.
111. Richard G, Brown N, Smith LE, Terrinoni A, Melino G, Mackie RM, Bale SJ, Uitto J. The spectrum of mutations in erythrokeratodermias-novel and de novo mutations in GJB3. Hum Genet. 2000;106:321-9.
112. Macari F, Landau M, Cousin P, Mevorah B, Brenner S, Panizzon R, Schorderet DF, Hohl D, Huber M. Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Am J Hum Genet. 2000;67:1296-301.
113. Richard G, Brown N, Rouan F, Van der Schroeff JG, Bijlsma E, Eichenfield LF, Sybert VP, Greer KE, Hogan P, Campanelli C, Compton JG, Bale SJ, DiGiovanna JJ, Uitto J. Genetic heterogeneity in erythrokeratodermia variabilis: Novel mutations in the connexin gene GJB4 (Cx30.3) and genotype-phenotype correlations. J Invest Dermatol. 2003;120:601-9.
114. Lamartine J, Munhoz Essenfelder G, Kibar Z, Lanneluc I, Callouet E, Laoudj D, Lemaffitre G, Hand C, Hayflick SJ, Zonana J, Antonarakis S, Radhakrishna U, Kelsell DP, Christianson AL, Pitaval A, der Kaloustian V, Fraser C, Blanchet-Bardon C, Rouleau GA, Waksman G. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet. 2000;26:142-4.
115. Shiels A, Mackay D, Ionides A, Berry V, Moore A, Bhattacharya S. A missense mutation in the human connexin50 gene (GJA8) underlies autosomal dominant 'zonular pulverulent' cataract, on chromosome 1q. Am J Hum Genet. 1998;62:526-32.
116. Mackay D, Ionides A, Kibar Z, Rouleau G, Berry V, Moore A, Shiels A, Bhattacharya S. Connexin46 mutations in autosomal dominant congenital cataract. AmJ Hum Genet. 1999;64:1357-64.
117. Paznekas WA, Boyadjiev SA, Shapiro RE, Daniels O, Wollnik B, Keegan CE, Innis JW, Dinulos MB, Christian C, Hannibal MC, JabsEW. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet. 2003;72:408-18.